作者:Dennis Pollok、Luca M. Großmann、Torsten Behrendt、Till Opatz、Siegfried R. Waldvogel
DOI:10.1002/chem.202201523
日期:2022.9.6
Highly pharmaceutically relevant Amaryllidaceae alkaloids have been accessed by a versatile electro-organic key transformation, including a precursor of the acetylcholinesterase inhibitor galantamine, used as FDA-approved drug for the treatment of Alzheimer's disease. Spirodienone-type intermediates were obtained in a regioselective and sustainable anodic key transformation from nature-derived starting
高度药学相关的石蒜科生物碱已通过多功能电有机关键转化获得,其中包括乙酰胆碱酯酶抑制剂加兰他敏的前体,该药物被 FDA 批准用作治疗阿尔茨海默病的药物。螺二烯酮型中间体是通过区域选择性和可持续的阳极关键转化从天然原料中获得的